Starting from enantiomeric pure 1-[(3S,5R)- and 1-[(3R,5S)-3-(hydroxymethyl)-2-methylisoxazolidin-5-yl]-5-methylpyrimidine-2,4(1H,3H)-diones (−)7a and (+)7b, obtained by lipase-catalyzed resolution, pure diethyl[(3S,5R)-2-methyl-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)isoxazolidin-3-yl]methyl}phosphonate (−)12a and diethyl[(3R,5S)-2-methyl-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)isoxazolidin-3-yl]methyl}phosphonate (+)12b have been synthesized. The obtained compounds showed no cytotoxic activity versus the U937 cell line in comparison with AZT, and were poorly able to inhibit HIV infection in vitro.
从
脂肪酶催化分解得到的对映体纯品1-[(3S,5R)-和1-[(3R,5S)-3-(羟甲基)-2-甲基
异恶唑烷-5-基]-5-
甲基嘧啶-2,4(1H,3H)-二酮(-)7a和(+)7b开始,纯品
二乙基[(3S,5R)-2-甲基-5-(5-甲基-2、(3R,5S)-2-甲基-5-(5-甲基-2,4-二氧代-3,4-二氢
嘧啶-1(2H)-基)
异恶唑烷-3-基]甲基}
膦酸二乙酯 (-)12a 和
二乙基[(3R,5S)-2-甲基-5-(5-甲基-2,4-二氧代-3,4-二氢
嘧啶-1(2H)-基)
异恶唑烷-3-基]甲基}
膦酸二乙酯 (+)12b 合成。与 AZT 相比,所获得的化合物对 U937
细胞系没有细胞毒性活性,对体外 HIV 感染的抑制能力也很差。